158 related articles for article (PubMed ID: 1510399)
1. Parasiticidal effect of clindamycin on Toxoplasma gondii grown in cultured cells and selection of a drug-resistant mutant.
Pfefferkorn ER; Nothnagel RF; Borotz SE
Antimicrob Agents Chemother; 1992 May; 36(5):1091-6. PubMed ID: 1510399
[TBL] [Abstract][Full Text] [Related]
2. Comparison of mutants of Toxoplasma gondii selected for resistance to azithromycin, spiramycin, or clindamycin.
Pfefferkorn ER; Borotz SE
Antimicrob Agents Chemother; 1994 Jan; 38(1):31-7. PubMed ID: 8141576
[TBL] [Abstract][Full Text] [Related]
3. Effect of clindamycin on intracellular replication, protein synthesis, and infectivity of Toxoplasma gondii.
Blais J; Tardif C; Chamberland S
Antimicrob Agents Chemother; 1993 Dec; 37(12):2571-7. PubMed ID: 7509143
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a mutant of Toxoplasma gondii resistant to aphidicolin.
Pfefferkorn ER
J Protozool; 1984 May; 31(2):306-10. PubMed ID: 6206226
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyurea inhibition of growth and DNA synthesis in Toxoplasma gondii: characterization of a resistant mutant.
Kasper LH; Pfefferkorn ER
Mol Biochem Parasitol; 1982 Sep; 6(3):141-50. PubMed ID: 6182467
[TBL] [Abstract][Full Text] [Related]
6. Toxoplasma gondii: in vivo and in vitro studies of a mutant resistant to arprinocid-N-oxide.
Pfefferkorn ER; Eckel ME; McAdams E
Exp Parasitol; 1988 Apr; 65(2):282-9. PubMed ID: 3350108
[TBL] [Abstract][Full Text] [Related]
7. Mutants of Toxoplasma gondii resistant to atovaquone (566C80) or decoquinate.
Pfefferkorn ER; Borotz SE; Nothnagel RF
J Parasitol; 1993 Aug; 79(4):559-64. PubMed ID: 8331476
[TBL] [Abstract][Full Text] [Related]
8. Arabinosyl nucleosides inhibit Toxoplasma gondii and allow the selection of resistant mutants.
Pfefferkorn ER; Pfefferkorn LC
J Parasitol; 1976 Dec; 62(6):993-9. PubMed ID: 1003290
[TBL] [Abstract][Full Text] [Related]
9. In vitro assays elucidate peculiar kinetics of clindamycin action against Toxoplasma gondii.
Fichera ME; Bhopale MK; Roos DS
Antimicrob Agents Chemother; 1995 Jul; 39(7):1530-7. PubMed ID: 7492099
[TBL] [Abstract][Full Text] [Related]
10. An rRNA mutation identifies the apicoplast as the target for clindamycin in Toxoplasma gondii.
Camps M; Arrizabalaga G; Boothroyd J
Mol Microbiol; 2002 Mar; 43(5):1309-18. PubMed ID: 11918815
[TBL] [Abstract][Full Text] [Related]
11. Toxoplasma gondii: characterization of a mutant resistant to sulfonamides.
Pfefferkorn ER; Borotz SE; Nothnagel RF
Exp Parasitol; 1992 May; 74(3):261-70. PubMed ID: 1582478
[TBL] [Abstract][Full Text] [Related]
12. High-throughput growth assay for Toxoplasma gondii using yellow fluorescent protein.
Gubbels MJ; Li C; Striepen B
Antimicrob Agents Chemother; 2003 Jan; 47(1):309-16. PubMed ID: 12499207
[TBL] [Abstract][Full Text] [Related]
13. Toxoplasma gondii: characterization of a mutant resistant to 6-thioxanthine.
Pfefferkorn ER; Borotz SE
Exp Parasitol; 1994 Nov; 79(3):374-82. PubMed ID: 7957757
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Toxoplasma gondii replication by dinitroaniline herbicides.
Stokkermans TJ; Schwartzman JD; Keenan K; Morrissette NS; Tilney LG; Roos DS
Exp Parasitol; 1996 Dec; 84(3):355-70. PubMed ID: 8948325
[TBL] [Abstract][Full Text] [Related]
15. Toxoplasma gondii: use of mutants to study the host-parasite relationship.
Pfefferkorn ER; Schwartzman JD; Kasper LH
Ciba Found Symp; 1983; 99():74-91. PubMed ID: 6557015
[TBL] [Abstract][Full Text] [Related]
16. Selection and characterization of Toxoplasma gondii mutants resistant to artemisinin.
Berens RL; Krug EC; Nash PB; Curiel TJ
J Infect Dis; 1998 Apr; 177(4):1128-31. PubMed ID: 9534999
[TBL] [Abstract][Full Text] [Related]
17. [Antibacterial activity of clindamycin and lincomycin in broth, serum, and in combination with polymorphonuclear leukocytes against Staphylococcus aureus and Staphylococcus epidermidis].
Bassler M; Just HM; Richter A; Zeller H; Daschner F
Infection; 1984; 12(4):280-5. PubMed ID: 6490174
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cytoplasmic and organellar protein synthesis in Toxoplasma gondii. Implications for the target of macrolide antibiotics.
Beckers CJ; Roos DS; Donald RG; Luft BJ; Schwab JC; Cao Y; Joiner KA
J Clin Invest; 1995 Jan; 95(1):367-76. PubMed ID: 7814637
[TBL] [Abstract][Full Text] [Related]
19. The biochemical basis for resistance to adenine arabinoside in a mutant of Toxoplasma gondii.
Pfefferkorn ER; Pfefferkorn LC
J Parasitol; 1978 Jun; 64(3):486-92. PubMed ID: 207846
[TBL] [Abstract][Full Text] [Related]
20. New micromethod to study the effect of antimicrobial agents on Toxoplasma gondii: comparison of sulfadoxine and sulfadiazine individually and in combination with pyrimethamine and study of clindamycin, metronidazole, and cyclosporin A.
Mack DG; McLeod R
Antimicrob Agents Chemother; 1984 Jul; 26(1):26-30. PubMed ID: 6383209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
